Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.21.2
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock
Private Placement
Common Stock
Additional Paid-in Capital
Private Placement
Additional Paid-in Capital
Accumulated Deficit
Convertible preferred stock (as converted to common stock)
Private Placement
Total
Balance at the beginning at Dec. 31, 2019           $ 72,883   $ 72,883
Balance at the beginning (in shares) at Dec. 31, 2019           74,170,214    
Convertible Preferred Stock                
Issuance of Series B-1 convertible preferred stock, net of issuance costs of $106           $ 2,994    
Issuance of Series B-1 convertible preferred stock, net of issuance costs of $105 (in shares)           3,207,773    
Balance at the end at Mar. 31, 2020           $ 75,877    
Balance at the end (in shares) at Mar. 31, 2020           77,377,987    
Balance at the beginning at Dec. 31, 2019   $ 1   $ 7,978 $ (66,489)     (58,510)
Balance at the beginning (in shares) at Dec. 31, 2019   8,621,846            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of warrants to purchase common stock       45       45
Issuance of common stock upon exercise of stock options       67       67
Issuance of common stock upon exercise of stock options (in shares)   281,500            
Stock-based compensation expense       62       62
Net loss         (6,430)     (6,430)
Balance at the end at Mar. 31, 2020   $ 1   8,152 (72,919)     (64,766)
Balance at the end (in shares) at Mar. 31, 2020   8,903,346            
Balance at the beginning at Dec. 31, 2019           $ 72,883   72,883
Balance at the beginning (in shares) at Dec. 31, 2019           74,170,214    
Balance at the end at Sep. 30, 2020           $ 75,877    
Balance at the end (in shares) at Sep. 30, 2020           77,377,987    
Balance at the beginning at Dec. 31, 2019   $ 1   7,978 (66,489)     (58,510)
Balance at the beginning (in shares) at Dec. 31, 2019   8,621,846            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of warrants to purchase common stock               45
Balance at the end at Sep. 30, 2020   $ 1   8,966 (84,285)     (75,318)
Balance at the end (in shares) at Sep. 30, 2020   8,929,174            
Balance at the beginning at Mar. 31, 2020           $ 75,877    
Balance at the beginning (in shares) at Mar. 31, 2020           77,377,987    
Balance at the end at Jun. 30, 2020           $ 75,877    
Balance at the end (in shares) at Jun. 30, 2020           77,377,987    
Balance at the beginning at Mar. 31, 2020   $ 1   8,152 (72,919)     (64,766)
Balance at the beginning (in shares) at Mar. 31, 2020   8,903,346            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options       3       3
Issuance of common stock upon exercise of stock options (in shares)   11,024            
Stock-based compensation expense       60       60
Net loss         (5,104)     (5,104)
Balance at the end at Jun. 30, 2020   $ 1   8,215 (78,023)     (69,807)
Balance at the end (in shares) at Jun. 30, 2020   8,914,370            
Balance at the end at Sep. 30, 2020           $ 75,877    
Balance at the end (in shares) at Sep. 30, 2020           77,377,987    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options       348       348
Issuance of common stock upon exercise of stock options (in shares)   14,804            
Stock-based compensation expense       403       403
Net loss         (6,262)     (6,262)
Balance at the end at Sep. 30, 2020   $ 1   8,966 (84,285)     (75,318)
Balance at the end (in shares) at Sep. 30, 2020   8,929,174            
Balance at the beginning at Dec. 31, 2020           $ 75,877   $ 75,877
Balance at the beginning (in shares) at Dec. 31, 2020           77,377,987   77,377,987
Balance at the end at Mar. 31, 2021           $ 75,877    
Balance at the end (in shares) at Mar. 31, 2021           77,377,987    
Balance at the beginning at Dec. 31, 2020   $ 1   9,194 (93,881)     $ (84,686)
Balance at the beginning (in shares) at Dec. 31, 2020   9,845,192            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of warrants to purchase common stock       1       1
Issuance of common stock upon exercise of stock options       455       455
Issuance of common stock upon exercise of stock options (in shares)   1,563,950            
Stock-based compensation expense       1,082       1,082
Net loss         (13,755)     (13,755)
Balance at the end at Mar. 31, 2021   $ 1   10,732 (107,636)     (96,903)
Balance at the end (in shares) at Mar. 31, 2021   11,409,142            
Balance at the beginning at Dec. 31, 2020           $ 75,877   $ 75,877
Balance at the beginning (in shares) at Dec. 31, 2020           77,377,987   77,377,987
Balance at the end (in shares) at Sep. 30, 2021               0
Balance at the beginning at Dec. 31, 2020   $ 1   9,194 (93,881)     $ (84,686)
Balance at the beginning (in shares) at Dec. 31, 2020   9,845,192            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with the closing of the Merger (in shares)               10,391,513
Issuance of common stock upon exercise of stock options (in shares)               2,399,609
Balance at the end at Sep. 30, 2021   $ 14   391,440 (107,256)     $ 284,198
Balance at the end (in shares) at Sep. 30, 2021   142,418,469            
Balance at the beginning at Mar. 31, 2021           $ 75,877    
Balance at the beginning (in shares) at Mar. 31, 2021           77,377,987    
Balance at the end at Jun. 30, 2021           $ 75,877    
Balance at the end (in shares) at Jun. 30, 2021           77,377,987    
Balance at the beginning at Mar. 31, 2021   $ 1   10,732 (107,636)     (96,903)
Balance at the beginning (in shares) at Mar. 31, 2021   11,409,142            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options       202       202
Issuance of common stock upon exercise of stock options (in shares)   1,993,936            
Stock-based compensation expense       535       535
Net loss         (22,371)     (22,371)
Balance at the end at Jun. 30, 2021   $ 1   11,469 (130,007)     $ (118,537)
Balance at the end (in shares) at Jun. 30, 2021   13,403,078            
Convertible Preferred Stock                
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger           $ (75,877)    
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger           (77,377,987)    
Balance at the end (in shares) at Sep. 30, 2021               0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger   $ 8   75,869       $ 75,877
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger (in shares)   80,873,772            
Issuance of common stock in connection with the closing of the Merger   $ 1   84,944       84,945
Issuance of common stock in connection with the closing of the Merger (in shares)   10,391,513            
Issuance of public warrants in connection with the closing of the Merger       (23,636)       (23,636)
Issuance of common stock in connection with the consummation of the PIPE Investment $ 3   $ 299,997       $ 300,000  
Issuance of common stock in connection with the consummation of the PIPE Investment (in shares) 30,000,000              
Issuance of common stock for net settlement of common stock and preferred stock warrants upon settlement of the Merger       880       880
Issuance of common stock for net settlement of common stock and preferred stock warrants upon settlement of the Merger (in shares)   2,029,712            
Issuance of common stock for the conversion of convertible notes   $ 1   53,644       53,645
Issuance of common stock for the conversion of convertible notes (in shares)   5,408,672            
Payment of deferred offering costs in connection with the closing of the Merger and PIPE Investment       (35,728)       (35,728)
Initial fair value of contingent earn-out liability recognized upon the closing of the Merger       (66,845)       (66,845)
Initial fair value of contingently issuable common stock liability recognized upon the closing of the Merger       (11,670)       (11,670)
Issuance of common stock upon exercise of stock options       120       120
Issuance of common stock upon exercise of stock options (in shares)   311,722            
Stock-based compensation expense       2,396       2,396
Net loss         22,751     22,751
Balance at the end at Sep. 30, 2021   $ 14   $ 391,440 $ (107,256)     $ 284,198
Balance at the end (in shares) at Sep. 30, 2021   142,418,469